Vildagliptin, a dipeptidyl peptidase-IV inhibitor improves model-assessed beta-cell function in patients with type 2 diabetes
Research output: Contribution to journal › Journal article › Research
Original language | English |
---|---|
Journal | J. Clin. Endocrinol. Metab. |
Issue number | 90 |
Pages (from-to) | 4888-4894 |
Publication status | Published - 2005 |
ID: 69022